
Kevin Joseph Fitzgerald
Insider
- 2024
- Apr 9, 2026
- 12
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kevin Joseph Fitzgerald files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Yvonne Greenstreet - $16.95M in ALNY purchases and sales in the last 12 months
- Pushkal Garg - $4.88M in ALNY purchases and sales in the last 12 months
- Jeffrey V. Poulton - $2.22M in ALNY purchases and sales in the last 12 months
- Tolga Tanguler - $1.88M in ALNY purchases and sales in the last 12 months
- Melissa McLaughlin - $1.27M in ALNY purchases and sales in the last 12 months
- David E. I. Pyott - $1.15M in ALNY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kevin Joseph Fitzgerald?
Kevin Joseph Fitzgerald is a corporate insider of Ovid Therapeutics Inc. (OVID). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kevin Joseph Fitzgerald last file a Form 4?
The most recent primary Form 4 on record is dated 9 April 2026, one of 12 filings going back to 2024.
Has Kevin Joseph Fitzgerald been buying or selling stock?
Recorded transactions: 0 open-market purchases and 68 open-market sales ($10.73M) across all tracked filings.